Dumayaca, Arwin .

HRN: 23-70-04  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/16/2024
11/23/2024
IV
300mg
Q6h
Diabetic Foot
Waiting Final Action 
11/16/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/16/2024
11/23/2024
IV
1.5g
Q8h
Diabetic Foot Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: